JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 90 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $29 | +70.6% | 15,468 | 0.0% | 0.00% | – |
| Q4 2022 | $17 | -100.0% | 15,468 | 0.0% | 0.00% | – |
| Q3 2022 | $36,000 | -21.7% | 15,468 | +0.9% | 0.00% | – |
| Q2 2022 | $46,000 | -55.8% | 15,334 | -0.2% | 0.00% | – |
| Q1 2022 | $104,000 | -70.1% | 15,372 | -63.1% | 0.00% | – |
| Q4 2021 | $348,000 | +11.2% | 41,706 | -1.0% | 0.00% | – |
| Q3 2021 | $313,000 | +9.8% | 42,119 | +0.5% | 0.00% | – |
| Q2 2021 | $285,000 | -43.3% | 41,921 | -14.3% | 0.00% | -100.0% |
| Q1 2021 | $503,000 | +46.6% | 48,934 | 0.0% | 0.00% | – |
| Q4 2020 | $343,000 | -15.3% | 48,934 | -1.4% | 0.00% | – |
| Q3 2020 | $405,000 | +18.4% | 49,634 | 0.0% | 0.00% | – |
| Q2 2020 | $342,000 | +109.8% | 49,634 | +44.5% | 0.00% | – |
| Q1 2020 | $163,000 | -15.5% | 34,356 | +55.2% | 0.00% | – |
| Q4 2019 | $193,000 | +153.9% | 22,134 | -2.6% | 0.00% | – |
| Q3 2019 | $76,000 | -29.0% | 22,734 | +5.3% | 0.00% | – |
| Q2 2019 | $107,000 | -21.9% | 21,584 | -2.3% | 0.00% | – |
| Q1 2019 | $137,000 | +80.3% | 22,084 | -1.8% | 0.00% | – |
| Q4 2018 | $76,000 | -48.6% | 22,484 | -1.3% | 0.00% | – |
| Q3 2018 | $148,000 | -15.4% | 22,784 | 0.0% | 0.00% | – |
| Q2 2018 | $175,000 | -65.9% | 22,784 | -0.7% | 0.00% | -100.0% |
| Q1 2018 | $513,000 | +75.7% | 22,934 | 0.0% | 0.00% | – |
| Q4 2017 | $292,000 | +239.5% | 22,934 | +317.0% | 0.00% | – |
| Q3 2017 | $86,000 | +11.7% | 5,500 | 0.0% | 0.00% | – |
| Q2 2017 | $77,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 662,063 | $10,315,000 | 30.07% |
| Omega Fund Management, LLC | 579,650 | $9,031,000 | 5.11% |
| Casdin Capital, LLC | 399,825 | $6,229,000 | 1.76% |
| Cormorant Asset Management, LP | 359,738 | $5,605,000 | 0.99% |
| Foresite Capital Management II, LLC | 119,912 | $1,868,000 | 0.76% |
| Redmile Group, LLC | 955,598 | $14,888,000 | 0.73% |
| PFM Health Sciences, LP | 1,727,997 | $26,922,000 | 0.53% |
| Fosun International Ltd | 285,960 | $4,455,000 | 0.44% |
| Partner Investment Management, L.P. | 14,265 | $222,000 | 0.21% |
| Spark Investment Management LLC | 162,200 | $2,527,000 | 0.14% |